2025 Event Guide

Thank you to our speakers, sponsors, and delegates who joined us in 2025!

If you are interested in the 2026 event, please get in touch at info@hansonwade.com

 

Browse the full Event Guide to discover:

4th Rare & Genetic Kidney Disease Drug Development

3 days packed full of high-quality talks from Astra Zeneca, Novartis, Takeda, Maze Therapeutics, Walden Biosciences and many more to provide you with key insights and takeaway actionable strategies

4th Rare & Genetic Kidney Disease Drug Development

Brand new search & evaluation and partnerships focussed panel discussion featuring Everest Medicine, Novartis, and Invizius Therapeutics to discuss how global partnerships can advance clinical development through broader patient reach

4th Rare & Genetic Kidney Disease Drug Development

6+ hours of dedicated networking sessions to forge industry partnerships allowing you to discover new targets, novel translational technology and leverage AI in clinical trials

Screenshot 2025-09-29 114932

Having trouble downloading the brochure? Let us know here and we’ll email it to you instead

Companies on the Program in 2025: